Methods for assessing arterial stiffness: Technical considerations

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 6, 2012, Pages 655-660

  Tomlinson, Laurie A ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

aortic stiffness; arterial stiffness; chronic kidney disease; pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN FIBER; ELASTIN; ENDOTHELIN 1; NITRIC OXIDE;

ALGORITHM; AORTA STENOSIS; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; BLOOD PRESSURE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FEMORAL ARTERY; FOLLOW UP; GOLD STANDARD; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE WAVE; REVIEW; RISK FACTOR; SMOOTH MUSCLE TONE;

ALGORITHMS; AORTA; BLOOD PRESSURE; EQUIPMENT DESIGN; HUMANS; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; VASCULAR STIFFNESS;

EID: 84868198407     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32835856e3     Document Type: Review

References (42)

1. Bramwell JC, Hill AV. Velocity of transmission of the pulse-wave and elasticity of the arteries. Lancet 1922; 199:891-892.
2. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
3. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
4. Avolio AP, Deng FQ, Li WQ, et al. Effects of aging on arterial distensibility in populations with high and lowprevalence of hypertension:comparison between urban and rural communities in China. Circulation 1985; 71:202-210.
5. Mourad JJ, Girerd X, Boutouyrie P, et al. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 1997; 30:1425-1430.
6. London GM, Marchais SJ, Guerin AP, et al. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int Suppl 1993; 41:S42-S49.
7. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200-204.
8. Ohtsuka S, Kakihana M,Watanabe H,Sugishita Y. Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. J Am Coll Cardiol 1994; 24:1406-1414.
9. Glagov S, Zarins C, Giddens DP, et al. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988; 112:1018-1031.
10. London GM, Marchais SJ, Safar ME, et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990; 37:137-142.
11. Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439.
12. Chue CD, Townend JN, Steeds RP, Ferro CJ. Arterial stiffness in chronic kidney disease: causes and consequences. Heart 2010; 96:817-823.
13. Townsend RR, Wimmer NJ, Chirinos JA, et al. Aortic PWV in chronic kidney disease: a CRIC Ancillary Study. Am J Hypertens 2009; 23:282-289.
14. Lilitkarntakul P, Dhaun N, Melville V, et al. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis 2011; 216:217-225.
15. Ford ML, Tomlinson LA, Chapman TP, et al. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 2010; 55:1110-1115.
16. Chue CD, Edwards NC, Davis LJ, et al. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant 2011; 26:2576-2582.
17. London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in endstage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18:1731-1740.
18. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in the arterial media. Hypertension 1998; 32:170-175.
19. Smith ER, Tomlinson LA, FordML, et al. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 2012; 59:973-978.
20. Schmitt M, Avolio A, Qasem A, et al. Basal NO locally modulates human iliac artery function in vivo. Hypertension 2005; 46:227-231.
21. Dhaun N, Macintyre IM, Melville V, et al. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension 2009; 54:113-119.
22. Maki-Petaja KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by antitumor necrosis factor-alpha therapy. Circulation 2006; 114:1185-1192.
23. Mattace-Raso FU, van der Cammen TJ, van der Meer IM, et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 2004; 176:111-116.
24. Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res 2009; 81:637-648.
25. Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012. [Epub ahead of print].
26. Savage MT, Ferro CJ, Pinder SJ, Tomson CR. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond) 2002; 103:59-65.
27. Sharman JE, Davies JE, Jenkins C, Marwick TH. Augmentation index, left ventricular contractility, and wave reflection. Hypertension 2009; 54:1099-1105.
28. Shirai K, Hiruta N, Song M, et al. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011; 18:924-938.
29. Farrar DJ, Bond MG, Riley WA, Sawyer JK. Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 1991; 83:1754-1763.
30. Frimodt-Moller M, Nielsen AH, Kamper AL, Strandgaard S. Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008; 23:594-600.
31. Pannier B, Guerin AP, Marchais SJ, et al. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 2005; 45:592-596.
32. Hickson SS, Butlin M, Broad J, et al. Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res 2009; 32:1079-1085.
33. Baulmann J, Schillings U, Rickert S, et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezoelectronic methods. J Hypertens 2008; 26:523-528.
34. Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448.
35. Huybrechts SA, Devos DG, Vermeersch SJ, et al. Carotid to femoral pulse wave velocity: a comparison of real travelled aortic path lengths determined by MRI and superficial measurements. J Hypertens 2011; 29:1577-1582.
36. Boutouyrie P, Vermeersch SJ. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31:2338-2350.
37. O'Rourke MF. Pulsatile arterial haemodynamics in hypertension. Aust N Z J Med 1976; 6 (Suppl. 2):40-48.
38. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the management of arterial hypertension: ESH-ESC Task Force on the management of arterial hypertension. J Hypertens 2007; 25:1751-1762.
39. Dhaun N, MacIntyre IM, Kerr D, et al. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease. Hypertension 2011; 57:772-779.
40. Edwards NC, Steeds RP, Stewart PM, et al. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 2009; 54:505-512.
41. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121: 505-511.
42. Chue CD, Townend JN, Steeds RP, Ferro CJ. Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial. Trials 2011; 12:30.